Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if udenafil improves exercise tolerance in patients with systolic heart failure.


Clinical Trial Description

Udenafil (Zydena), a newly developed PDE-5 inhibitor, has been proved to have similar efficacy and safety profile, compared with other PDE-5 inhibitors. Also, laboratory data showed that udenafil inhibits ventricular hypertrophy and fibrosis in rat heart failure model. Based on these results, the investigators hypothesized that udenafil would improve symptom, exercise capacity and hemodynamic status in patients with systolic heart failure. In this 12-week, randomized, double-blind, placebo-controlled trial, patients with systolic heart failure will be enrolled according to the eligibility criteria. After randomization, study participants will be assigned to receive either 50mg of udenafil or placebo two times a day for 4 weeks, and then the dosage will be doubled to 100mg two times a day for next 8 weeks. Participants will attend study visits at baseline and weeks 4 and 12. Physical examination, medical history review, blood sample collection and electrocardiogram will be conducted on each study visits. At baseline and week 12, participants will undergo cardiopulmonary exercise test and exercise echocardiography. At every study visits,researchers will collect health information. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01646515
Study type Interventional
Source Seoul National University Hospital
Contact
Status Terminated
Phase Phase 3
Start date December 2011
Completion date January 2014

See also
  Status Clinical Trial Phase
Completed NCT02026102 - A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs) N/A
Active, not recruiting NCT00949676 - DECIDE-HF: Heart Rate Variability in Heart Failure Patients N/A
Recruiting NCT03157219 - Manipal Heart Failure Registry (MHFR) N/A
Recruiting NCT05230732 - Neuromodulation of Inflammation and Endothelial Function N/A
Completed NCT04065893 - Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy
Completed NCT02223403 - Effect of Nitrate-rich Beetroot Juice on Exercise Performance in Heart Failure Patients N/A
Completed NCT02946853 - Junctional AV Ablation in CRT-D: JAVA-CRT N/A
Completed NCT00833352 - Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device N/A
Terminated NCT02958098 - My Research Legacy Pilot Study
Enrolling by invitation NCT03984591 - A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure Phase 4
Completed NCT02156583 - Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients
Recruiting NCT01566344 - Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes N/A
Withdrawn NCT01127334 - Pilot Study Using Echocardiography to Evaluate Patients With Heart Failure and Dyssynchrony Who Have a CRT-D Device N/A
Completed NCT03534297 - Study of Dapansutrile Capsules in Heart Failure Phase 1
Completed NCT01765400 - Platelet Inhibition in Patients With Systolic Heart Failure Phase 4
Completed NCT01814319 - Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure Phase 2
Recruiting NCT02637167 - GutHeart: Targeting Gut Microbiota to Treat Heart Failure Phase 2
Suspended NCT03755570 - How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
Completed NCT02084992 - A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure N/A
Completed NCT04937790 - Effects of Postural Balance Exercises in Patients With Heart Failure N/A